search
Back to results

The Effects of One Month Consumption of Standardized Aronia Melanocarpa Extract on Anemia in Patients on Hemodialysis

Primary Purpose

Renal Disease, Dialysis; Complications, Anemia

Status
Terminated
Phase
Not Applicable
Locations
Serbia
Study Type
Interventional
Intervention
Alixir 400 Protect
Sponsored by
University of Kragujevac
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Renal Disease focused on measuring hemodialysis, anemia, oxidative stress, inflammation

Eligibility Criteria

37 Years - 68 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • regular dialysis treatment for more than 3 months, 3 times a week
  • hemoglobin values lower than 110g / L

Exclusion Criteria:

  • hemoglobin values lower than 80g/L,
  • the use of antioxidant and immunosuppressive therapy,
  • uncontrolled malignancies,
  • proven active bleeding
  • presence of systemic inflammation or active infection

Sites / Locations

  • Faculty of Medical Science

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Experimental group

Arm Description

Patients on hemodialysis who consumed one month Standardized Aronia Melanocrpa extract

Outcomes

Primary Outcome Measures

Anemia control
The iron levels Unit µmol/l
Anemia control
The hemoglobin levels Unit g/l
Anemia control
The ferritin levels Unit ng/ml
Anemia control
The transferrin levels Unit g/l

Secondary Outcome Measures

Oxidative stress
Superoxide anion radical, Hydrogen peroxide, Nitrites Units nmol/ml
Oxidative stress
Superoxide dismutase, Catalase Units U/g Hb x 1000
Oxidative stress
Reduced glutathione Unit nmol/l RBC x 1000

Full Information

First Posted
December 18, 2019
Last Updated
December 21, 2019
Sponsor
University of Kragujevac
Collaborators
Pharmanova d.o.o., Obrenovac, Serbia
search

1. Study Identification

Unique Protocol Identification Number
NCT04208451
Brief Title
The Effects of One Month Consumption of Standardized Aronia Melanocarpa Extract on Anemia in Patients on Hemodialysis
Official Title
The Effects of One Month Consumption of Standardized Aronia Melanocarpa Extract on Anemia in Patients on Hemodialysis: Focus on Oxidative Stress and Inflammation
Study Type
Interventional

2. Study Status

Record Verification Date
December 2019
Overall Recruitment Status
Terminated
Why Stopped
All required data are already collected.
Study Start Date
August 1, 2019 (Actual)
Primary Completion Date
October 1, 2019 (Actual)
Study Completion Date
October 1, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Kragujevac
Collaborators
Pharmanova d.o.o., Obrenovac, Serbia

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
In this study are included patients on hemodialysis with anemia (levels of Hemoglobin<110). After baseline measurements tha patients take Standardized Aronia melanocarpa extract for one mont and then all measurements were repeated.
Detailed Description
Patients The study included 30 patients with chronic kidney failure on dialysis treatment at the Center for Nephrology and Dialysis of the Clinical Center Kragujevac. Inclusion criteria were: regular dialysis treatment for more than 3 months, 3 times a week and hemoglobin values lower than 110g / L. Exclusion criteria were: hemoglobin values lower than 80g/L, the use of antioxidant and immunosuppressive therapy, uncontrolled malignancies, proven active bleeding and presence of systemic inflammation or active infection. Ethical approval The research was conducted with respect to the Helsinki Declaration on Medical Research, the approval of the Ethics Committee of the Clinical Center Kragujevac No 01-14-3039. All subjects provided written informed consent before study enrollment. Used plant extract Standardized Aronia extract (SAE) is official product of pharmaceutical company Pharmanova (Belgrade, Serbia); nevertheless, procedure of extraction was done by EU-Chem company (Belgrade, Serbia). This product contains 400mg/30ml of polyphenols, while the recommended daily dosage is 30ml. Blood sampling Patients included in the study consumed standardized Aronia melanocarpa extract (30ml/day) for 30 days. On the day 0, before SAE consumption, blood samples from all patients were collected for hematologic analyzes, inflammation parameters, oxidative stress parameters and antioxidant protection before the dialysis procedure. All mentioned parameters were determined again after consuming the product, ie. on the 30th day of the study. Analytic Procedures Venous blood samples (2 x 4.5ml) were taken before the start of supplementation (zero day) and at the end of supplementation (30th day). Vacuum tubes with sodium citrate were used for blood sampling. The first sample was used for routine hematologic analyzes, the second sample was used for plasma and erythrocyte lysate extraction in order to determinate redox and inflammatory status. Evaluation of Systemic Redox State Plasma samples were used for determination of the levels of the following pro-oxidants: superoxide anion radical (O2-), hydrogen peroxide (H2O2), nitrites (NO2-) and index of lipid peroxidation measured as thiobarbituric acid reactive substances (TBARS), while the parameters of antioxidative defence system, such as activities of superoxide dismutase (SOD) and catalase (CAT) and level of reduced glutathione (GSH) were determined in erythrocytes lysates samples. A) Index of lipid peroxidation (TBARS) determination The degree of lipid peroxidation in the plasma samples was estimated by measuring TBARS, using 1% thiobarbituric acid in 0.05 NaOH, which was incubated with the sample at 100°C for 15 min and measured at 530 nm. TBA extract was obtained by combining 0.8 ml sample and 0.4 ml trichloro acetic acid (TCA); afterwards, the samples were put on ice for 10 min and centrifuged for 15 min at 6000 rpm. (1). b) Nitrite determination (NO2-) Nitric oxide (NO) decomposes rapidly to form stable nitrite/nitrate products. The NO2- level was measured and used as an index of NO production, using Griess's reagent. For NO2 - determination in plasma 0.1 ml 3 N PCA (perchloride acid), 0.4 ml 20 mM ethylenediaminetetraacetic acid (EDTA) and 0.2 ml plasma were put on ice for 15 min, then centrifuged for 15 min at 6000 rpm. After pouring off the supernatant, 220 μl K2CO3 was added. Nitrites were measured at 550 nm. (2) Superoxide anion radical determination (O2-) Superoxide anion radical concentrations in plasma samples were measured using the NTB (Nitro Blue Tetrazolium) reagent in TRIS buffer (assay mixture). The measurement was performed at a wavelength of 530 nm. (3). Hydrogen peroxide determination (H2O2) The measurement of H2O2 was based on the oxidation of phenol red by H2O2 in a reaction catalyzed by horseradish peroxidase. Two hundred microlitres of perfusate or plasma was precipitated using 800 mL of freshly prepared phenol red solution; 10 μL of (1:20) horseradish peroxidase (made immediately before use) was subsequently added. The level of H2O2 was measured at 610 nm (4). Determination of reduced glutathione (GSH) The level of reduced glutathione (GSH) was determined based on GSH oxidation via 5,5-dithiobis-6,2-nitrobenzoic acid. GSH extract was obtained by combining 0.1 ml 0.1% EDTA, 400 μl hemolysate, and 750 μl precipitation solution (containing 1.67 g metaphosphoric acid, 0.2 g EDTA, 30 g NaCl, and filled with distilled water until 100 ml; the solution is stable for 3 weeks at +4C°). The level of GSH was measured at 420 nm (5). Determination of antioxidant enzymes (SOD, CAT) Isolated RBCs were washed three times with three volumes of ice-cold 0.9 mmol/l NaCl, and hemolysates containing about 50 g Hb/l were used for the determination of CAT activity. CAT buffer, prepared hemolysate sample, and 10 mM H2O2 were used for CAT determination. Detection was performed at 360 nm. SOD activity was determined by the epinephrine method. Hemolysate was mixed with carbonate buffer, and then epinephrine was added. Detection was performed at 470 nm (6-10). Evaluation of the inflammatory status In order to evaluate the inflammatory status of patients, following parameters were measured at both points of interest (0 and 30th day): serum C-reactive protein concentration - CRP and tumor necrosis factor concentration - TNF-α. The serum C- reactive protein (CRP) concentration was determined by the turbidimetric method on the Olympus AU680. The normal serum CRP concentration is ≤ 5 mg/L. Microinflammation is defined as the concentration of CRP in the serum of 5 mg/L. Plasma TNF-α concentrations were determined by enzyme linked immunoadsorbent assay (ELISA) using commercially available high sensitivity indirect sandwich enzyme-linked immunosorbent assay (Sigma Aldrich). Evaluation of the hematological parameters At both points of interest, the values of the following haematological parameters in all patients were analyzed: Erythrocytes (Er), hemoglobin (Hb), hematocrit (Hct), erythrocyte index- mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), serum lactate dehydrogenase concentration (LDH), serum haptoglobin concentration and iron status: serum iron concentration, ferritin; total iron binding capacity (TIBC), unsaturated iron binding capacity (UIBC), transferrin saturation (TSAT), haptoglobin. Statistical Analysis IBM SPSS Statistics 20.0 Desktop for Windows was used for statistical analysis. Shapiro-Wilk test was used to check the distribution of data. Statistical comparisons were performed using the one-way analysis of variance (ANOVA) tests with a Tukey's post hoc test for multiple comparisons, in the case of normal distribution of data between groups, while Kruskal-Wallis was used for comparison between groups where the distribution of data was different than normal. Values of p < 0.05 were considered to be statistically significant.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Renal Disease, Dialysis; Complications, Anemia
Keywords
hemodialysis, anemia, oxidative stress, inflammation

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
30 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Experimental group
Arm Type
Experimental
Arm Description
Patients on hemodialysis who consumed one month Standardized Aronia Melanocrpa extract
Intervention Type
Dietary Supplement
Intervention Name(s)
Alixir 400 Protect
Intervention Description
During 30 days all patients take every day 30ml of Alixir 400 protect
Primary Outcome Measure Information:
Title
Anemia control
Description
The iron levels Unit µmol/l
Time Frame
two months
Title
Anemia control
Description
The hemoglobin levels Unit g/l
Time Frame
two months
Title
Anemia control
Description
The ferritin levels Unit ng/ml
Time Frame
two months
Title
Anemia control
Description
The transferrin levels Unit g/l
Time Frame
two months
Secondary Outcome Measure Information:
Title
Oxidative stress
Description
Superoxide anion radical, Hydrogen peroxide, Nitrites Units nmol/ml
Time Frame
two months
Title
Oxidative stress
Description
Superoxide dismutase, Catalase Units U/g Hb x 1000
Time Frame
two months
Title
Oxidative stress
Description
Reduced glutathione Unit nmol/l RBC x 1000
Time Frame
two months
Other Pre-specified Outcome Measures:
Title
Inflammation
Description
The parameters of inflammation CRP Unit mg/l
Time Frame
two months
Title
Inflammation
Description
The parameters of inflammation TNF alpha Unit pg/ml
Time Frame
two months
Title
Inflammation
Description
The parameters of inflammation white blood cells Unit x 1000000000 cells/l
Time Frame
two months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
37 Years
Maximum Age & Unit of Time
68 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: regular dialysis treatment for more than 3 months, 3 times a week hemoglobin values lower than 110g / L Exclusion Criteria: hemoglobin values lower than 80g/L, the use of antioxidant and immunosuppressive therapy, uncontrolled malignancies, proven active bleeding presence of systemic inflammation or active infection
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Isidora Milosavljevic
Organizational Affiliation
Department of pharmacy, University of Kragujevac
Official's Role
Principal Investigator
Facility Information:
Facility Name
Faculty of Medical Science
City
Kragujevac
ZIP/Postal Code
34000
Country
Serbia

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
34327604
Citation
Milosavljevic I, Jakovljevic V, Petrovic D, Draginic N, Jeremic J, Mitrovic M, Zivkovic V, Srejovic I, Stojic V, Bolevich S, Andjelkovic N. Standardized Aronia melanocarpa extract regulates redox status in patients receiving hemodialysis with anemia. Mol Cell Biochem. 2021 Nov;476(11):4167-4175. doi: 10.1007/s11010-021-04225-y. Epub 2021 Jul 29.
Results Reference
derived

Learn more about this trial

The Effects of One Month Consumption of Standardized Aronia Melanocarpa Extract on Anemia in Patients on Hemodialysis

We'll reach out to this number within 24 hrs